tiprankstipranks
Bioatla, Inc. (BCAB)
:BCAB
US Market

BioAtla (BCAB) Similar Stocks

Compare
542 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BioAtla
$0.41
$26.03M
-83.55%
0 Buy
0 Hold
0 Sell
Moderate Buy
Fate Therapeutics
$1.42
$175.97M
-79.21%
3 Buy
2 Hold
0 Sell
Moderate Buy
Affimed
$1.04
$15.53M
-80.49%
3 Buy
0 Hold
0 Sell
Strong Buy
Zai Lab
$33.78
$3.42B
69.66%
1 Buy
0 Hold
0 Sell
Moderate Buy
ADC Therapeutics
$1.63
$161.47M
-65.25%
3 Buy
0 Hold
0 Sell
Strong Buy
Immatics
$4.60
$549.04M
-61.70%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
BCAB
BioAtla
0.41
-1.95
-82.63%
FATE
Fate Therapeutics
1.42
-5.46
-79.36%
AFMD
Affimed
1.04
-4.29
-80.49%
ZLAB
Zai Lab
33.78
13.70
68.23%
ADCT
ADC Therapeutics
1.63
-3.26
-66.67%
IMTX
Immatics
4.60
-7.46
-61.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis